Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438940 · ClinicalTrials.gov registry record · NA
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients
A NA study of GastroEsophageal Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Active
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT05438940: Active NA study of GastroEsophageal Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT05438940 is a NA study of GastroEsophageal Cancer that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 23 participants, below the 496-participant average among 23 other GastroEsophageal Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05438940, a NA study of GastroEsophageal Cancer, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastroesophageal cancer who are receiving chemotherapy and radiation treatment
Primary Outcome
The study will be deemed feasible if ≥ 50% of eligible participants are enrolled
Conditions Studied
Interventions
- BEHAVIORAL Fitbit Data Collection
- BEHAVIORAL Nutrition Counseling
- BEHAVIORAL Survey
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT05438940 still lists
NCT05438940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 496-participant average among 23 other GastroEsophageal Cancer trials with a reported enrollment target (95% lower).
The record links to 1 condition, with GastroEsophageal Cancer appearing as the primary indexed condition, and to 3 interventions - of which Fitbit Data Collection is the first listed.
NCT05438940 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05438940 about?
NCT05438940 is a clinical study titled "Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients". The purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastroesophageal cancer who are receiving chemotherapy and radiation...
What is the current status of trial NCT05438940?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2022-07-15. Estimated completion is 2026-06.
What conditions does trial NCT05438940 study?
This clinical trial studies the following conditions: GastroEsophageal Cancer.
What interventions are being tested in trial NCT05438940?
The interventions under investigation include: Fitbit Data Collection (BEHAVIORAL), Nutrition Counseling (BEHAVIORAL), Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT05438940?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05438940 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for GastroEsophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05438940's enrollment target sits among peer trials
23 19th of 23 higher than 5 of 23 other GastroEsophageal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other GastroEsophageal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
RECRUITING · NA
-
Supportive Oncology Care At Home RCT
ACTIVE NOT RECRUITING · NA
-
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
RECRUITING · Phase 2
-
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
RECRUITING · Phase 2
-
Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI